Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Objective: To assess the effect of treatment with MK-0822 5 mg once daily on the risk of developing a first bone metastasis (first disease recurrence) compared to placebo Objective: To assess the effect of treatment with MK-0822 5 mg once daily on disease-free survival compared to placebo Objective: To assess the effect of treatment with MK-0822 5 mg once daily in a subset of 250 patients on lumbar spine, total hip, femoral neck, trochanter and total body bone mineral density (BMD) compared to placebo Objective: To assess the tolerability of treatment with MK-0822 5 mg once daily compared to placebo
Critère d'inclusion
- Prevention of disease recurrence in patients with breast cancer